Pyoderma Gangrenosum

Wounds

Volumn 11, Issue 2 SUPPL. B, 1999, Pages

  Hoffman, Mark D ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007396194     PISSN: 10447946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Brunsting LA, Goeckerman WH, O'Leary PA. Pyoderma (ecthyma) gangrenosum: Clinical and experimental observations in five cases occurring in adults. Arch Dermatol:1930;22:655-80.
2. Powell FC, Perry HO. Pyoderma gangrenosum in childhood. Arch Dermatol 1984;120:757-61.
3. Powell FC, Su WPD, Perry HO. Pyoderma gangrenosum: Classification and management. J Am Acad Dermatol 1996;34:395-409.
4. Callen J. Pyoderma gangrenosum. Lancet 1998;351:581-5.
5. Koester G, Tarnower A, Levisohn D, Burgdorf W. Bullous pyoderma gangrenosum. J Am Acad Dermatol 1993;29:875-8.
6. Prystowsky JH, Kahn SN, Lazarus GS. Present status of pyoderma gangrenosum: Review of 21 cases. Arch Dennatol 1989;125:57-64.
7. Su WPD, Schroeter AL, Perry HO, Powell FC. Histopathologic and immunopathologic study of pyoderma gangrenosum. J Cutan Pathol 1986; 13:323-30.
8. Magro C, Crowson AN, Mihm M. Cutaneous manifestations of nutritional deficiency states and gastrointestinal disease. In: Elder D (ed). Lever's Histopathology of the Skin. Philadelphia: Lippincott-Raven, 1997:357-8.
9. Powell FC, Schroeter AL, Su WPD, Perry HO. Pyoderma gangrenosum: A review of 86 patients. Quar J Med 1985;55:173-86.
10. Talansky AL, Meyers S, Greenstein AJ, Janowitz HD. Does intestinal resection heal the pyoderma gangrenosum of inflammatory bowel disease? J Clin Gastroenterol 1983;5:207-10.
11. Janowitz HD. Pyoderma gangrenosum. Lancet 1998;351:1134.
12. Cox NH, Peebles-Brown DA, MacKie RM. Pyoderma gangrenosum occurring 10 years after proctocolectomy for ulcerative colitis. Br J Hosp Med 1986;36:363.
13. Romano J, Safai B. Pyoderma gangrensoum and myeloproliferative disorders: Report of a case and review of the literature. Arch Intern Med 1979;139:932-4.
14. Lazarus GS, Goldsmith LA, Rocklin RE, et al. Pyoderma gangrenosum, altered delayed hypersensitivity, and polyarthritis. Arch Dermatol 1972;105:46-51.
15. Papi M, Didona B, Chinni LM, et al. Koebner phenomenon in an ANCA-positive patient with pyoderma gangrenosum. J Dermatol 1997;24:583-6.
16. Porteau-Cassard L, Marc V, Dromer C, Fournie B. Polyarthritis with perinuclear antineutrophil cytoplasmic antibody and pyoderma gangrenosum: Report of a case. Rev Rheum [Engl Ed] 1997;64:847-8.
17. Bayle P, Laplanche G, Gorguet B, et al. Neutrophilic dermatosis: A case of overlapping syndrome with monoclonal antineutrophil cytoplasmic autoantibody activity. Dermatology 1994; 189:69-71.
18. Irvine AD, Bruce IN, Walsh M, Burrows D, Handley J. Dermatological presentation of disease associated with antineutrophil cytoplasmic antibodies: A report of two contrasting cases and a review of the literature. Br J Dermatol 1996;134:924-8.
19. Abad E, Tural C, Mirapeix E, Cuxart A. Relationship between ANCA and clinical activity in inflammatory bowel disease: Variation in prevalence of ANCA and evidence of heterogeneity. J Autoimmun 1997;10:175-80.
20. Frances C, Du LTH, Piette JC, et al. Wegener's granulomatosis: Dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol 1994;130:861-7.
21. Dwarakanath AD, Yu LG, Brookes C, Pryce D, Rhodes J M. "Sticky" neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis. Gut 1995;37:585-8.
22. Shore RN. Pyoderma gangrenosum, defective neutrophil chemotaxis, and leukemia. Arch Dermatol 1976;112:1792-3.
23. Shaya S, Kindzelskii AL, Minor J, Moore EC, Todd RF, Petty HR. Aberrant integrin (CR4; alphaxbeta2; CD11/CD18) oscillations on neutrophils in a mild form of pyoderma gangrenosum. J Invest Dermatol 1998;111:154-8.
24. Adachi Y, Kindzelskii AL, Cookingham G, et al. Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum. J Invest Dermatol 1998;111:259-68.
25. Hood A. Superficial and deep infiltrates of the skin. In: Farmer ER, Hood AF, (eds). Pathology of the Skin. Norwalk (CN): Appleton & Lange, 1990:205.
26. Lorentzen H, Gottrup F. Misclassification errors of ulcerative pyoderma gangrenosum. Wound Rep Reg 1998;6:A475.
27. Ho VC, Liu H, Mc Lean DI. Cyclosporine in nonpsoriatic dermatoses. J Am Acad Dermatol 1990;23:1248-59.
28. Mrowietz U, Christophers E. Clearing of pyoderma gangrenosum by intralesional cyclosporin A [letter]. Br J Dermatol 1991;125:499.
29. Schuppe HC, Homey B, Assmann T, Martens R, Ruzicka T. Topical tacrolimus for pyoderma gangrenosum. Lancet 1998;351:832.
30. Vereecken P, Wautrecht JC, De Dobbeleer G, Heenen M. A case of pyoderma gangrenosum stabilized with lymecycline, topical benzoyl peroxide and treated by autograft. Dermatology 1997; 195:50-1.
31. Chow RKP, Ho VC. Treatment of pyoderma gangrenosum. J Am Acad Dermatol 1996;34:1047-60.
32. Holt PJA, Davies MG, Saunders KC, Nuki G. Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine 1980;59:114-33.
33. Matis WL, Ellis CN, Griffiths CEM, Lazarus GS. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol 1992;128:1060-4.
34. Ackerman C, Abu-Elagd K, Venkataramanan K, Fung J, Todo S, Starzyl T, Jegasothy B. Recalcitrant psoriasis and pyoderma gangrenosum treated with FK 506 [Abstract]. J Invest Dermatol 1991;96:536.
35. Abu-Elmagd K, Jegasothy BV, Ackerman CD, et al. Efficacy of FK 506 in the treatment of recalcitrant pyoderma gangrenosum. Transplant Proc 1991;23:3328-9.
36. Abu-Elmagd K, Van Thiel DH, Jegasothy BV, et al. Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). Ann Intern Med 1993;119:595-8.
37. Cooley, HM, Castelino D, Mc Nair P, et al. Resolution of pyoderma gangrenosum using tacrolimus (FK-506). Aust NZ J Med 1996:26:238-9.